Back
MannKind 10K Form
Buy
59
MNKD
MannKind
Last Price:
4.59
Seasonality Move:
7.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | MNKD/MannKind Quarterly |
| 2023-11-07 | 10Q | MNKD/MannKind Quarterly |
| 2023-08-07 | 10Q | MNKD/MannKind Quarterly |
| 2023-05-09 | 10Q | MNKD/MannKind Quarterly |
| 2022-11-08 | 10Q | MNKD/MannKind Quarterly |
| 2022-08-09 | 10Q | MNKD/MannKind Quarterly |
Receive MNKD News And Ratings
See the #1 stock for the next 7 days that we like better than MNKD
MNKD Financial Statistics
Sales & Book Value
| Annual Sales: | $198.96M |
|---|---|
| Cash Flow: | $4.3M |
| Price / Cash Flow: | 437.78 |
| Annual Sales: | $-0.85 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.04000 |
|---|---|
| Net Income (TTM): | $8.49M |
| Gross Margin: | $136.19M |
| Return on Equity: | 0% |
| Return on Assets: | 2.25% |
MannKind Earnings Forecast
Key MannKind Financial Ratios
- The Gross Profit Margin over the past 19 years for MNKD is 68.45%.
- The Selling, General & Administrative Expenses for MNKD have been equal to 47.40% of Gross Profit Margin.
- The Research & Development expenses have been 15.72% of Revenue.
- The Interest Expense is -210.76% of Operating Income.
- The Net Earning history of MNKD is -6.00% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
MannKind Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNKD |
| CUSIP: | 56400P |
| Website: | mannkindcorp.com |
Debt
| Debt-to-Equity Ratio: | -1.15 |
|---|---|
| Current Ratio: | 3.84 |
| Quick Ratio: | 3.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 20.86 |